WallStreetZenWallStreetZen

NASDAQ: CTKB
Cytek Biosciences Inc Stock Ownership - Who owns Cytek Biosciences?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Cytek Biosciences Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Patrik JeanmonodChief Financial Officer2023-11-243,000$6.94
$20.82kSell
Ming YanChief Technology Officer2023-11-2020,000$6.03
$120.60kSell
Wenbin JiangPresident and CEO2023-11-183,965$5.98
$23.71kSell
Valerie BarnettGeneral Counsel2023-11-181,434$5.98
$8.58kSell
Valerie BarnettGeneral Counsel2023-11-18786$5.98
$4.70kSell
Ming YanChief Technology Officer2023-11-18772$5.98
$4.62kSell
Paul Christopher WilliamsChief Operating Officer2023-11-181,569$5.98
$9.38kSell
Ming YanChief Technology Officer2023-11-182,431$5.98
$14.54kSell
Patrik JeanmonodChief Financial Officer2023-11-18683$5.98
$4.08kSell
Patrik JeanmonodChief Financial Officer2023-11-181,434$5.98
$8.58kSell

1 of 9

CTKB insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CTKB insiders and whales buy or sell their stock.

CTKB Shareholders

What type of owners hold Cytek Biosciences Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc12.37%16,770,673$122.76MInstitution
Brown Capital Management LLC10.00%13,560,480$99.26MInstitution
Ra Capital Management LP9.87%13,381,054$97.95MInsider
Vanguard Group Inc8.17%11,079,421$81.10MInstitution
Wenbin Jiang5.87%7,954,695$58.23MInsider
Ming Yan5.73%7,762,103$56.82MInsider
Ra Capital Management LP5.02%6,809,404$49.84MInstitution
Hhlr Advisors Ltd4.91%6,657,030$48.73MInstitution
State Street Corp2.79%3,777,543$27.65MInstitution
Geode Capital Management LLC1.74%2,354,452$17.23MInstitution

1 of 3

CTKB vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CTKB57.09%22.03%Net SellingNet Selling
AHCO44.47%55.53%Net SellingNet Selling
AVNS93.12%2.41%Net SellingNet Selling
FNA13.86%86.14%Net SellingNet Selling
QTRX64.31%35.69%Net BuyingNet Selling
View Top Medical Device Stocks

Cytek Biosciences Stock Ownership FAQ

Who owns Cytek Biosciences?

Cytek Biosciences (NASDAQ: CTKB) is owned by 57.09% institutional shareholders, 22.03% Cytek Biosciences insiders, and 20.88% retail investors. Ra Capital Management LP is the largest individual Cytek Biosciences shareholder, owning 13.38M shares representing 9.87% of the company. Ra Capital Management LP's Cytek Biosciences shares are currently valued at $102.50M.

If you're new to stock investing, here's how to buy Cytek Biosciences stock.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.